Adding Nubeqa to androgen deprivation therapy improved radiographic progression-free survival in patients with metastatic hormone-sensitive prostate cancer. The combination of Nubeqa (darolutamide) ...
ADT announced its new ADT Plus smart security system, which features new hardware and more integration possibilities with Google Nest cameras and video doorbells. It also allows you to set up trusted ...
Darolutamide plus androgen deprivation therapy (ADT), without docetaxel, significantly prolonged radiographic progression-free survival compared with placebo plus ADT in patients with metastatic ...
A partitioned-survival lifetime model (2025 USD) compared ADT alone with seven intensification strategies across PFS, post-progression, and death, using published survival curves and literature-based ...
Posts from this topic will be added to your daily email digest and your homepage feed. A Trusted Neighbor feature, coming to the new ADT Plus system, automates access to your home for people you trust ...
ADT is a pioneer in home security with highly customizable wireless and hardwired security options. ADT’s indoor, outdoor, and doorbell cameras are all smart-home ready, which can lower your home ...
PCa Diagnoses Fall in Wake of USPSTF Screening Recommendation Adding bevacizumab to androgen deprivation therapy (ADT) resulted in improved relapse-free survival in patients with hormone-sensitive ...
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non–Small-Cell Lung Cancer ...
BOCA RATON, Fla. — In spite of challenging market conditions ADT has shown admirable financial growth in the third quarter thanks to bulk account acquisition and partnerships with other major ...
BOCA RATON, Fla. — ADT entered the second half of 2025 with 4% total revenue growth, amid a slight dip in recurring monthly revenue (RMR), but the company remains confident in the strength of its ...
A 1-year period of intensified androgen receptor blockade prolonged prostate-specific antigen progression-free survival (PSA-PFS) compared with androgen deprivation therapy (ADT) alone for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results